Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo after First-Line Chemotherapy in Patients with Metastatic Urothelial Cancer

  • Matthew D. Galsky
  • , Amir Mortazavi
  • , Matthew I. Milowsky
  • , Saby George
  • , Sumati Gupta
  • , Mark T. Fleming
  • , Long H. Dang
  • , Daniel M. Geynisman
  • , Radhika Walling
  • , Robert S. Alter
  • , Mohamad Kassar
  • , Jue Wang
  • , Shilpa Gupta
  • , Nancy Davis
  • , Joel Picus
  • , George Philips
  • , David I. Quinn
  • , G. Kenneth Haines
  • , Noah M. Hahn
  • , Qianqian Zhao
    • Menggang Yu, Sumanta K. Pal

Research output: Contribution to journal › Article › peer-review

120 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo after First-Line Chemotherapy in Patients with Metastatic Urothelial Cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science